Literature DB >> 11568341

Thymic lesions in patients with myasthenia gravis: characterization with thallium 201 scintigraphy.

T Higuchi1, J Taki, S Kinuya, M Yamada, M Kawasuji, O Matsui, A Nonomura, H Bunko, N Tonami.   

Abstract

PURPOSE: To assess thallium 201 ((201)Tl) single photon emission computed tomography (SPECT) for evaluation of thymic lesions associated with myasthenia gravis (MG), including lymphoid follicular hyperplasia (LFH) and thymoma.
MATERIALS AND METHODS: (201)Tl SPECT and computed tomography (CT) were performed preoperatively in 46 patients with MG who had undergone thymectomy. SPECT was conducted 15 (early image) and 180 (delayed image) minutes after (201)Tl injection. Results were visually assessed, and (201)Tl uptake ratios (thymic lesion count density/lung count density) were measured for quantitative analysis. Uptake was analyzed among the normal thymus, LFH, and thymoma patient groups.
RESULTS: Histopathologic results indicated a normal thymus, LFH, and thymoma in 19, 16, and 11 patients, respectively. Mean uptake ratios in the normal thymus, LFH, and thymoma were 0.96 (95% CI: 0.90, 1.03), 1.14 (95% CI: 1.04, 1.25), and 1.87 (95% CI: 1.56, 2.25), respectively, on early images and 1.09 (95% CI: 1.00, 1.18), 1.65 (95% CI: 1.48, 1.85), and 2.03 (95% CI: 1.65, 2.50), respectively, on delayed images. Thymoma showed more intense (201)Tl accumulation than did the normal thymus (P <.001) and LFH (P <.001) on early images. Both thymoma (P <.001) and LFH (P <.001) displayed more intense uptake than did the normal thymus on delayed images.
CONCLUSION: (201)Tl SPECT can enable differentiation between normal thymus, LFH, and thymoma in patients with MG.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11568341     DOI: 10.1148/radiol.2211001047

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

1.  Thymectomy in myasthenia gravis: comparison of outcome in Santiago, Cuba and Nottingham, UK.

Authors:  N Shahrizaila; O A Pacheco; D G Vidal; F R Miyares; A J Wills
Journal:  J Neurol       Date:  2005-10-05       Impact factor: 4.849

2.  Evaluation of anterior mediastinal solid tumors by CT perfusion: a preliminary study.

Authors:  Selim Bakan; Sedat Giray Kandemirli; Atilla Süleyman Dikici; Ezel Erşen; Onur Yıldırım; Cesur Samancı; Şebnem Batur; Deniz Çebi Olgun; Fatih Kantarcı; Canan Akman
Journal:  Diagn Interv Radiol       Date:  2017 Jan-Feb       Impact factor: 2.630

3.  Application values of 99mTc-methoxyisobutylisonitrile imaging for differentiating benign and malignant thymic masses.

Authors:  Chenghui Lu; Xufu Wang; Bin Liu; Xinfeng Liu; Guoming Wang; Qin Zhang
Journal:  Oncol Lett       Date:  2017-06-21       Impact factor: 2.967

4.  Using CT to evaluate mediastinal great vein invasion by thymic epithelial tumors: measurement of the interface between the tumor and neighboring structures.

Authors:  Shoji Kuriyama; Kazuhiro Imai; Koichi Ishiyama; Shinogu Takashima; Maiko Atari; Tsubasa Matsuo; Yoshiaki Ishii; Yuzu Harata; Yusuke Sato; Satoru Motoyama; Kyoko Nomura; Manabu Hashimoto; Yoshihiro Minamiya
Journal:  Eur Radiol       Date:  2021-09-23       Impact factor: 5.315

5.  Somatostatin receptor scintigraphy in the follow-up of myasthenia gravis.

Authors:  Z R Gao; C Kornblum; S Flacke; T Logvinski; M Yüksel; R An; T Klockgether; H J Biersack; S Ezziddin
Journal:  Neurol Sci       Date:  2007-08-10       Impact factor: 3.307

6.  Thymic pathologies in myasthenia gravis: a preoperative assessment of CAT scan and nuclear based imaging.

Authors:  Berit Jordan; Juliane Kellner; Karin Jordan; Manfred Bähre; Curd Behrmann; Stephan Zierz
Journal:  J Neurol       Date:  2016-01-25       Impact factor: 4.849

Review 7.  Thymomas: review of current clinical practice.

Authors:  Sandra Tomaszek; Dennis A Wigle; Shaf Keshavjee; Stefan Fischer
Journal:  Ann Thorac Surg       Date:  2009-06       Impact factor: 4.330

Review 8.  The Effect of Diagnostic Imaging on Surgical Treatment Planning in Diseases of the Thymus.

Authors:  Aurel Ottlakan; Bernadett Borda; Zita Morvay; Aniko Maraz; Jozsef Furak
Journal:  Contrast Media Mol Imaging       Date:  2017-01-10       Impact factor: 3.161

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.